Fresenius Kabi Recalls Heparin Sodium Injection Due to Subpotency
Fresenius Kabi USA recalls specific lots of Heparin Sodium Injection because the drug may be subpotent, posing a risk of ineffective treatment.
Use caution until it’s fixed
Subpotent; 18 month time point
Contact the company
What happened, in plain English
Fresenius Kabi USA, LLC is recalling one lot of Heparin Sodium Injection, USP 10,000 USP units per 10 mL. The product was found to be subpotent at the 18-month time point, meaning it may not contain enough active ingredient to work as intended. No remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/46305-fresenius-kabi-usa-llc-recalls-heparin-sodium-injection-usp-10.
Source Summary by GovInfoNow · govinfonow.com/recall/46305-fresenius-kabi-usa-llc-recalls-heparin-sodium-injection-usp-10 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1148-2014
Cite this page
“Fresenius Kabi Recalls Heparin Sodium Injection Due to Subpotency.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46305-fresenius-kabi-usa-llc-recalls-heparin-sodium-injection-usp-10. Based on FDA recall #D-1148-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1148-2014%22&limit=1).
Why it’s dangerous
The recalled vials are classified as 'subpotent,' which means the concentration of heparin is lower than labeled. If used, the patient may not receive the therapeutic anticoagulant effect needed to prevent or treat blood clots, potentially leading to serious health complications.
Who’s affected
Patients who have been prescribed or received Heparin Sodium Injection for intravenous (IV) or subcutaneous (SC) use. Individuals relying on this specific medication for blood clotting management are at risk of receiving an ineffective dose.
How to tell if you have this one
Check if you have Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) in a multi-dose vial. Specifically look for NDC 63323-540-11, Lot Number 6004137, and an expiration date of 06/2014.
- Brand
Fresenius Kabi- Category
Drug
What to do — step by step
Check Your Medication
Verify if your vial matches NDC 63323-540-11, Lot Number 6004137, and expiration date 06/2014.
Contact Your Healthcare Provider
Speak with your doctor or pharmacist immediately to discuss alternative treatments if you possess the recalled lot.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.3 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Fresenius Kabi recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1148-2014 (January 22, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1148-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.